Literature DB >> 20448045

A flavin-dependent monooxygenase from Mycobacterium tuberculosis involved in cholesterol catabolism.

Carola Dresen1, Leo Y-C Lin, Igor D'Angelo, Elitza I Tocheva, Natalie Strynadka, Lindsay D Eltis.   

Abstract

Mycobacterium tuberculosis (Mtb) and Rhodococcus jostii RHA1 have similar cholesterol catabolic pathways. This pathway contributes to the pathogenicity of Mtb. The hsaAB cholesterol catabolic genes have been predicted to encode the oxygenase and reductase, respectively, of a flavin-dependent mono-oxygenase that hydroxylates 3-hydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17-dione (3-HSA) to a catechol. An hsaA deletion mutant of RHA1 did not grow on cholesterol but transformed the latter to 3-HSA and related metabolites in which each of the two keto groups was reduced: 3,9-dihydroxy-9,10-seconandrost-1,3,5(10)-triene-17-one (3,9-DHSA) and 3,17-dihydroxy-9,10-seconandrost-1,3,5(10)-triene-9-one (3,17-DHSA). Purified 3-hydroxy-9,10-seconandrost-1,3,5(10)-triene-9,17-dione 4-hydroxylase (HsaAB) from Mtb had higher specificity for 3-HSA than for 3,17-DHSA (apparent k(cat)/K(m) = 1000 +/- 100 M(-1) s(-1) versus 700 +/- 100 M(-1) s(-1)). However, 3,9-DHSA was a poorer substrate than 3-hydroxybiphenyl (apparent k(cat)/K(m) = 80 +/- 40 M(-1) s(-1)). In the presence of 3-HSA the K(m)(app) for O(2) was 100 +/- 10 microM. The crystal structure of HsaA to 2.5-A resolution revealed that the enzyme has the same fold, flavin-binding site, and catalytic residues as p-hydroxyphenyl acetate hydroxylase. However, HsaA has a much larger phenol-binding site, consistent with the enzyme's substrate specificity. In addition, a second crystal form of HsaA revealed that a C-terminal flap (Val(367)-Val(394)) could adopt two conformations differing by a rigid body rotation of 25 degrees around Arg(366). This rotation appears to gate the likely flavin entrance to the active site. In docking studies with 3-HSA and flavin, the closed conformation provided a rationale for the enzyme's substrate specificity. Overall, the structural and functional data establish the physiological role of HsaAB and provide a basis to further investigate an important class of monooxygenases as well as the bacterial catabolism of steroids.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20448045      PMCID: PMC2903365          DOI: 10.1074/jbc.M109.099028

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Rapid automated molecular replacement by evolutionary search.

Authors:  C R Kissinger; D K Gehlhaar; D B Fogel
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-02

2.  Characterization of 4-hydroxyphenylacetate 3-hydroxylase (HpaB) of Escherichia coli as a reduced flavin adenine dinucleotide-utilizing monooxygenase.

Authors:  L Xun; E R Sandvik
Journal:  Appl Environ Microbiol       Date:  2000-02       Impact factor: 4.792

3.  Functional analysis of the small component of the 4-hydroxyphenylacetate 3-monooxygenase of Escherichia coli W: a prototype of a new Flavin:NAD(P)H reductase subfamily.

Authors:  B Galán; E Díaz; M A Prieto; J L García
Journal:  J Bacteriol       Date:  2000-02       Impact factor: 3.490

4.  A novel two-protein component flavoprotein hydroxylase.

Authors:  P Chaiyen; C Suadee; P Wilairat
Journal:  Eur J Biochem       Date:  2001-11

5.  Characterization of chlorophenol 4-monooxygenase (TftD) and NADH:flavin adenine dinucleotide oxidoreductase (TftC) of Burkholderia cepacia AC1100.

Authors:  Michelle R Gisi; Luying Xun
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

6.  Targeted disruption of the kstD gene encoding a 3-ketosteroid delta(1)-dehydrogenase isoenzyme of Rhodococcus erythropolis strain SQ1.

Authors:  R van Der Geize; G I Hessels; R van Gerwen; J W Vrijbloed; P van Der Meijden; L Dijkhuizen
Journal:  Appl Environ Microbiol       Date:  2000-05       Impact factor: 4.792

7.  Characterization of a two-component alkanesulfonate monooxygenase from Escherichia coli.

Authors:  E Eichhorn; J R van der Ploeg; T Leisinger
Journal:  J Biol Chem       Date:  1999-09-17       Impact factor: 5.157

8.  Molecular and functional characterization of the kstD2 gene of Rhodococcus erythropolis SQ1 encoding a second 3-ketosteroid Delta(1)-dehydrogenase isoenzyme.

Authors:  Robert van der Geize; Gerda I Hessels; Lubbert Dijkhuizen
Journal:  Microbiology       Date:  2002-10       Impact factor: 2.777

9.  Molecular and functional characterization of kshA and kshB, encoding two components of 3-ketosteroid 9alpha-hydroxylase, a class IA monooxygenase, in Rhodococcus erythropolis strain SQ1.

Authors:  R van der Geize; G I Hessels; R van Gerwen; P van der Meijden; L Dijkhuizen
Journal:  Mol Microbiol       Date:  2002-08       Impact factor: 3.501

Review 10.  Molecular genetics of Mycobacterium tuberculosis pathogenesis.

Authors:  Josephine E Clark-Curtiss; Shelley E Haydel
Journal:  Annu Rev Microbiol       Date:  2003       Impact factor: 15.500

View more
  42 in total

1.  Pathway profiling in Mycobacterium tuberculosis: elucidation of cholesterol-derived catabolite and enzymes that catalyze its metabolism.

Authors:  Suzanne T Thomas; Brian C VanderVen; David R Sherman; David G Russell; Nicole S Sampson
Journal:  J Biol Chem       Date:  2011-11-01       Impact factor: 5.157

2.  Interactions with the substrate phenolic group are essential for hydroxylation by the oxygenase component of p-hydroxyphenylacetate 3-hydroxylase.

Authors:  Chanakan Tongsook; Jeerus Sucharitakul; Kittisak Thotsaporn; Pimchai Chaiyen
Journal:  J Biol Chem       Date:  2011-11-03       Impact factor: 5.157

3.  Structure and mechanism of ORF36, an amino sugar oxidizing enzyme in everninomicin biosynthesis .

Authors:  Jessica L Vey; Ahmad Al-Mestarihi; Yunfeng Hu; Michael A Funk; Brian O Bachmann; T M Iverson
Journal:  Biochemistry       Date:  2010-11-02       Impact factor: 3.162

Review 4.  The Minimal Unit of Infection: Mycobacterium tuberculosis in the Macrophage.

Authors:  Brian C VanderVen; Lu Huang; Kyle H Rohde; David G Russell
Journal:  Microbiol Spectr       Date:  2016-12

Review 5.  The tuberculosis drug discovery and development pipeline and emerging drug targets.

Authors:  Khisimuzi Mdluli; Takushi Kaneko; Anna Upton
Journal:  Cold Spring Harb Perspect Med       Date:  2015-01-29       Impact factor: 6.915

6.  Withdrawn

Authors: 
Journal:  Infect Disord Drug Targets       Date:  2012-11-16

Review 7.  Updating and curating metabolic pathways of TB.

Authors:  Richard A Slayden; Mary Jackson; Jeremy Zucker; Melissa V Ramirez; Clinton C Dawson; Rebecca Crew; Nicole S Sampson; Suzanne T Thomas; Neema Jamshidi; Peter Sisk; Ron Caspi; Dean C Crick; Michael R McNeil; Martin S Pavelka; Michael Niederweis; Axel Siroy; Valentina Dona; Johnjoe McFadden; Helena Boshoff; Jocelyne M Lew
Journal:  Tuberculosis (Edinb)       Date:  2013-02-01       Impact factor: 3.131

8.  Activity of 3-ketosteroid 9α-hydroxylase (KshAB) indicates cholesterol side chain and ring degradation occur simultaneously in Mycobacterium tuberculosis.

Authors:  Jenna K Capyk; Israël Casabon; Robert Gruninger; Natalie C Strynadka; Lindsay D Eltis
Journal:  J Biol Chem       Date:  2011-10-10       Impact factor: 5.157

9.  Tuning of pKa values activates substrates in flavin-dependent aromatic hydroxylases.

Authors:  Warintra Pitsawong; Pirom Chenprakhon; Taweesak Dhammaraj; Dheeradhach Medhanavyn; Jeerus Sucharitakul; Chanakan Tongsook; Willem J H van Berkel; Pimchai Chaiyen; Anne-Frances Miller
Journal:  J Biol Chem       Date:  2020-02-02       Impact factor: 5.157

10.  Degradation of the acyl side chain of the steroid compound cholate in Pseudomonas sp. strain Chol1 proceeds via an aldehyde intermediate.

Authors:  Johannes Holert; Žarko Kulić; Onur Yücel; Vemparthan Suvekbala; Marc J-F Suter; Heiko M Möller; Bodo Philipp
Journal:  J Bacteriol       Date:  2012-11-30       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.